Randomized controlled trials are also needed to determine whether statins can actually reduce the risk for hepatocellular ...

By that time the cholestasis was more pronounced, and there was slight focal or disseminated fatty degeneration. Neither hepatocellular necrosis nor evidence of reactive inflammation was found (Fig.

Statin users had a significantly lower 10-year cumulative incidence of hepatocellular carcinoma and hepatic decompensation.

"To our knowledge, our study represents the first randomized, global study to report data for an anti-TIGIT monoclonal ...

This is called secondary liver cancer or liver metastases. Hepatocellular carcinoma is also called hepatoma or HCC. It's the most common type of primary liver cancer. Because of this, the information ...

Deep-learning (DL) radiopathomics models can help predict the presence of vessels encapsulating tumour clusters (VETC) in ...

Hepatocellular carcinoma (HCC), the most common type of primary liver cancer, accounts for about 75–85% of all liver cancer cases. Immune checkpoint ...

Progression-free survival was significantly greater in the durvalumab plus bevacizumab group compared to placebo. 2. Common treatment-related adverse events included hypertension and anemia. Evidence ...